The global biologics Contract Development and Manufacturing Organization (CDMO) market has witnessed remarkable growth in recent years and continues to gain momentum. Valued at USD 17.26 billion in 2023, the market is expected to expand at a Compound Annual Growth Rate (CAGR) of 9.12% during the forecast period, reaching USD 34.64 billion by 2031. This upward trajectory highlights increasing...

The global biologics Contract Development and Manufacturing Organization (CDMO) market has witnessed remarkable growth in recent years and continues to gain momentum. Valued at USD 17.26 billion in 2023, the market is expected to expand at a Compound Annual Growth Rate (CAGR) of 9.12% during the forecast period, reaching USD 34.64 billion by 2031. This upward trajectory highlights increasing...